PRÊT1D: screening earlier, acting fairer regarding type 1 diabetes!
PRÊT1D – National project for the screening and management of presymptomatic type 1 diabetes, NEWLY SUPPORTED by the FFRD Background The recently published French position…

«Promoting and supporting research on diabetes
and metabolic diseases»
For the advancement of diabetes research
‼️ FFRD news et presentation or the 2025 awardees to the press ‼️
As every year begins, the FFRD is delighted to promote its awardees and their projects while reflecting on the key moments of 2025
In 2026, the FFRD has several new developments in progress: the renewal of the FFRD Call for Proposals, PRÊT1D, a new national study supported by the FFRD and a new FFRD symposium on “Epigénétics and Diabetes” at the SFD Congress in Lyon and still strenghtened partnerships!
Together, let’s keep promoting and supporting research on diabetes, the pathophysiology of its various forms, its prevention and management, its comorbidities and complications…
For the advancement of diabetes research and REDUCE THE BURDEN OF THE DISEASE 🩸
PRÊT1D – National project for the screening and management of presymptomatic type 1 diabetes, NEWLY SUPPORTED by the FFRD Background The recently published French position…
Launch of the FFRD 2026 Call for Proposals
Clinical, basic, and translational research
Teams of Francophone researchers
2 projects for a total of €500,000 (max)
Advanced Technology & Treatments for Diabetes
Developing new partnerships and collaborations
Strengthen the reputation of the FFRD
Enhance its visibility

The Francophone Foundation for Diabetes Research (FFRD) serves as the “armed wing” of the Francophone Diabetes Society (SFD) with the aim of promoting excellence in diabetes research, a common disease whose prevalence continues to rise. High-level and large-scale research is truly essential to get further insight into the mechanisms involved in the development of diabetes and its complications, as well as to improve their treatment and prevention.
The FFRD supports clinical, basic, and translational research.
The supported basic research projects address major themes of type 1 and type 2 diabetes
covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.
The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes
and often involve large multicenter cohort studies.
Since 2013, the Foundation has been:

